Is Hepatitis C Virus Elimination in Well-Defined Patient Groups Possible?

Jürgen Kurt Rockstroh^{1

2}

Affiliations

¹ Department of Medicine I, University Hospital Bonn.
² German Centre for Infection Research, partner site Bonn-Cologne, Bonn, Germany.

Comment

Jürgen Kurt Rockstroh. Clin Infect Dis. 2018.

. 2018 Apr 17;66(9):1366-1367.

doi: 10.1093/cid/cix1010.

Jürgen Kurt Rockstroh^{1

2}

¹ Department of Medicine I, University Hospital Bonn.
² German Centre for Infection Research, partner site Bonn-Cologne, Bonn, Germany.

No abstract available

Comment on

Declining Hepatitis C Virus (HCV) Incidence in Dutch Human Immunodeficiency Virus-Positive Men Who Have Sex With Men After Unrestricted Access to HCV Therapy.
Boerekamps A, van den Berk GE, Lauw FN, Leyten EM, van Kasteren ME, van Eeden A, Posthouwer D, Claassen MA, Dofferhoff AS, Verhagen DWM, Bierman WF, Lettinga KD, Kroon FP, Delsing CE, Groeneveld PH, Soetekouw R, Peters EJ, Hullegie SJ, Popping S, van de Vijver DAMC, Boucher CA, Arends JE, Rijnders BJ. Boerekamps A, et al. Clin Infect Dis. 2018 Apr 17;66(9):1360-1365. doi: 10.1093/cid/cix1007. Clin Infect Dis. 2018. PMID: 29186320
High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands.
Boerekamps A, Newsum AM, Smit C, Arends JE, Richter C, Reiss P, Rijnders BJA, Brinkman K, van der Valk M; NVHB-SHM Hepatitis Working Group and the Netherlands ATHENA HIV Observational Cohort. Boerekamps A, et al. Clin Infect Dis. 2018 Apr 17;66(9):1352-1359. doi: 10.1093/cid/cix1004. Clin Infect Dis. 2018. PMID: 29186365